Calpain-specific breakdown fragment in human drusen

• Published in: Histology and histopathology Vol. 39; no. 2; p. 165
• Main Authors: Orihara, Kana, Kobayashi-Otsugu, Momoko, Nakajima, Emi, Walkup, Ryan D, Wilson, David J, Shearer, Thomas R, Azuma, Mitsuyoshi
• Format: Journal Article
• Language: English
• Published: Spain 01.02.2024
• Subjects: Calpain; Humans; Hypoxia; Macular Degeneration - metabolism; Retina - metabolism; Retinal Drusen - etiology; Retinal Drusen - metabolism
• ISSN: 1699-5848
• DOI: 10.14670/HH-18-635

With aging and age-related macular dystrophy (AMD), proteolytic fragments are deposited in extracellular drusen located between the RPE and Bruch's membrane. Localized hypoxia may be a risk factor for AMD. Our hypothesis is that following hypoxia, activation of proteolytic enzymes called calpains may cause proteolysis/degeneration of retinal cells and RPE. No direct evidence has yet demonstrated activation of calpains in AMD. The purpose of the present study was to identify calpain-cleaved proteins in drusen. Seventy-six (76) drusen were analyzed in human eye sections from six normal and twelve AMD human donor eyes. The sections were subjected to immunofluorescence for the calpain-specific 150 kDa breakdown product from α-spectrin, SBDP150 - a marker for calpain activation, and for recoverin - a marker for photoreceptor cells. Among 29 nodular drusen, 80% from normal eyes and 90% from AMD eyes stained positive for SBDP150. Among 47 soft drusen, mostly from AMD eyes, 72% stained positive for SBDP150. Thus, the majority of both soft and nodular drusen from AMD donors contained SBDP150. SBDP150 was detected for the first time in soft and nodular drusen from human donors. Our results suggest that calpain-induced proteolysis participates in the degeneration of photoreceptors and/or RPE cells during aging and AMD. Calpain inhibitors may ameliorate AMD progression.